Focused on developing targeted therapies for rare diseases and cancer, the company is a clinical-stage biopharmaceutical firm with a pipeline centered on precision oncology and genetically defined conditions. Its lead programs include treatments for desmoid tumors and neurofibromatosis type 1–associ...
Market Cap: $3.5B52W Range: $28.21 – $62.00
This page tracks all publicly disclosed congressional trades in SpringWorks Therapeutics, Inc. (SWTX), a company in the Healthcare sector. 3 members of Congress have disclosed trades in this stock, including 4 purchases and 3 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.